|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑
7 r, q9 D' G% N- U9 J/ ~& |2 E @2 b( b1 h. R
今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了
5 W }+ M% J; M& E- `0 b, o" V) U1 q2 X
头颈肿瘤BU入选ASCO 2025的研究
2 ^' P" l$ D7 X6 \. R( pHot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.5 s0 G8 n' }5 p) ^
肿瘤内科-头颈肿瘤科姜愚团队. F M: g' N% g# S1 F; A4 \
) C$ f0 Z& o, KNeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.
& e( }) r; { u& s( X- W5 I$ P9 [肿瘤内科-头颈肿瘤科刘磊团队- a+ a# K" t7 l
* H3 C) I0 p# ^- c4 \! HA phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.
& s& ]" }/ b1 f G# q+ B肿瘤内科-头颈肿瘤科刘磊团队
/ q# Q9 U* U& s( S5 W7 D" w- d y( `6 Q
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.8 D* u" M, O y/ s6 ?5 J" O+ _
肿瘤内科-头颈肿瘤科刘磊团队- T& {* ^, d8 d/ z
: ~6 @+ c2 q2 o5 Y; p1 R+ w2 \" Oribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
" C1 k; u4 m8 S% A% @3 t/ a肿瘤内科-头颈肿瘤科姜愚团队
0 w, Z* ?3 z- u+ R" x- e0 r |
|
[复制链接]
发表于 2025-5-2 09:58:22
